본문 바로가기
KERD
논문KCI 등재

A Case of Community-Acquired Pneumonia Caused by Multidrug-Resistant Acinetobacter baumannii in Korea

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류내과학

초록

Acinetobacter baumannii is an aerobic Gram-negative coccobacillus that causes nosocomial pneumonia in patients on mechanical ventilation or previously treated with broad-spectrum antibiotics. Nevertheless, community-acquired pneumonia (CAP) caused by A. baumannii, especially multi-drug resistant (MDR) strains, is rare. We experienced the first case of CAP caused by MDR A. baumannii in Korea in a 78-year-old man. This case shows that MDR A. baumannii can cause CAP in Korea.

Abstract

Acinetobacter baumannii is an aerobic Gram-negative coccobacillus that causes nosocomial pneumonia in patients on mechanical ventilation or previously treated with broad-spectrum antibiotics. Nevertheless, community-acquired pneumonia (CAP) caused by A. baumannii, especially multi-drug resistant (MDR) strains, is rare. We experienced the first case of CAP caused by MDR A. baumannii in Korea in a 78-year-old man. This case shows that MDR A. baumannii can cause CAP in Korea.

참고문헌 (18)

  1. Fournier PE, "The epidemiology and control of Acinetobacter baumannii in health care facilities", Clin Infect Dis, 42, pp.692~699 (2006)
  2. Towner KJ, "Acinetobacter: an old friend, but a new enemy", J Hosp Infect, 73, pp.355~363 (2009)
  3. Leung WS, "Fulminant community-acquired Acinetobacter baumannii pneumonia as a distinct clinical syndrome", Chest, 129, pp.102~109 (2006)
  4. Papp-Wallace KM, "Carbapenems: past, present, and future", Antimicrob Agents Chemother, 55, pp.4943~4960 (2011)
  5. Kang SJ, "Epidemiology and clinical features of community-onset Acinetobacter baumannii infections", Infect control Hosp Epidemilo, 33, pp.1053~1055 (2012)
  6. Falagas ME, "Community- acquired Acinetobacter infections", Eur J Clin Microbiol Infect Dis, 26, pp.857~868 (2007)
  7. Richet HM, "Building communication networks: international network for the study and prevention of emerging antimicrobial resistance", Emerg Infect Dis, 7, pp.319~322 (2001)
  8. 이경원, "Further Increases in Carbapenem-, Amikacin-, and Fluoroquinolone-Resistant Isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR Study 2009", Yonsei Medical Journal, 52(5), pp.793~802 (2011), 연세대학교의과대학
  9. 한상훈, "Acinetobacter baumannii 원인균이 의심되느 지역 사회 획득성 폐렴", Tuberculosis and Respiratory Diseases, 63(3), pp.273~277 (2007), 대한결핵및호흡기학회
  10. Kang CI, "Clinical outcomes and risk factors of community-acquired pneumonia caused by gram-negative bacilli", Eur J Clin Microbiol Infect Dis, 27, pp.657~661 (2008)
  11. 나주영, "A Probable Community-Acquired Pneumonia due to Acinetobacter baumannii Infection Presenting the Positive Pneumothorax Test at Autopsy", 대한법의학회지, 34(2), pp.125~128 (2010), 대한법의학회
  12. 이유미, "균혈증이 동반된 중증 지역사회 획득 Acinetobacter baumannii 폐렴 1예", Infection and Chemotherapy, 44(2), pp.71~74 (2012), 대한감염학회[DOI]
  13. 오윤정, "A case of fulminant community-acquired Acinetobacter baumannii pneumonia in Korea", The Korean Journal of Internal Medicine, 28(4), pp.486~490 (2013), 대한내과학회[DOI]
  14. Ong CW, "Severe community-acquired Acinetobacter baumannii pneumonia: an emerging highly lethal infectious disease in the Asia-Pacific", Respirology, 14, pp.1200~1205 (2009)
  15. Anstey NM, "Community-acquired Acinetobacter pneumonia in the Northern Territory of Australia", Clin Infect Dis, 14, pp.83~91 (1992)
  16. Kempf M, "Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options", Int J Antimicrob Agents, 39, pp.105~114 (2012)
  17. 이창섭, "Therapy of Infections due to Carbapenem-Resistant Gram-Negative Pathogens", Infection and Chemotherapy, 46(3), pp.149~164 (2014), 대한감염학회
  18. Zavascki AP, "Combination therapy for carbapenem-resistant Gram-negative bacteria", Expert Rev Anti Infect Ther, 11, pp.1333~1353 (2013)

관련 논문AI추천

이 간행물의 다른 논문 (10건)